Arbutus Biopharma
ABUS
#6192
Rank
A$1.30 B
Marketcap
A$6.81
Share price
-3.39%
Change (1 day)
32.40%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): A-$0.40

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is A-$0.39. In 2024 the company made an earnings per share (EPS) of A-$0.57 an increase over its 2023 EPS that were of A-$0.66.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.40-29.79%
2024A-$0.57-13.64%
2023A-$0.66-4.35%
2022A-$0.69-44.58%
2021A-$1.24-17%
2020A-$1.49-65.4%
2019A-$4.31138.84%
2018A-$1.81-22.44%
2017A-$2.33-78.45%
2016A-$10.81424.64%
2015A-$2.06-20.19%
2014A-$2.5887.96%
2013A-$1.37-142.59%
2012A$3.22-342.7%
2011A-$1.33-25.82%
2010A-$1.7947.8%
2009A-$1.21-43.55%
2008A-$2.15158.91%
2007A-$0.83-111.88%
2006A$6.98-552.53%
2005A-$1.54-71.77%
2004A-$5.46-14.48%
2003A-$6.39-8.95%
2002A-$7.0270.07%
2001A-$4.1348.01%
2000A-$2.79-38.54%
1999A-$4.53-24.6%
1998A-$6.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
NRC Health
NRC
A$1.04-369.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
A-$0.08955-76.92% Bahamas